These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27816027)

  • 21. Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease.
    Al-Bachari S; Parkes LM; Vidyasagar R; Hanby MF; Tharaken V; Leroi I; Emsley HC
    Neuroimage Clin; 2014; 6():1-8. PubMed ID: 25379411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive function and left ventricular assist device implantation.
    Bhat G; Yost G; Mahoney E
    J Heart Lung Transplant; 2015 Nov; 34(11):1398-405. PubMed ID: 26169667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor structure of the Montreal Cognitive Assessment items in a sample with early Parkinson's disease.
    Benge JF; Balsis S; Madeka T; Uhlman C; Lantrip C; Soileau MJ
    Parkinsonism Relat Disord; 2017 Aug; 41():104-108. PubMed ID: 28572020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validity and diagnostics of the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson's disease patients.
    D'Iorio A; Aiello EN; Amboni M; Vitale C; Verde F; Silani V; Ticozzi N; Ciammola A; Poletti B; Santangelo G
    Aging Clin Exp Res; 2023 Oct; 35(10):2157-2163. PubMed ID: 37480503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of Quantitative EEG to the Diagnosis of Early Cognitive Impairment in Patients With Idiopathic Parkinson's Disease.
    Guner D; Tiftikcioglu BI; Tuncay N; Zorlu Y
    Clin EEG Neurosci; 2017 Sep; 48(5):348-354. PubMed ID: 27491643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes on brief cognitive instruments over time in Parkinson's disease.
    Lessig S; Nie D; Xu R; Corey-Bloom J
    Mov Disord; 2012 Aug; 27(9):1125-8. PubMed ID: 22692724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease.
    Lucza T; Karádi K; Kállai J; Weintraut R; Janszky J; Makkos A; Komoly S; Kovács N
    Behav Neurol; 2015; 2015():983606. PubMed ID: 26078489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors Influencing Cognitive Function in Subjects With COPD.
    Dag E; Bulcun E; Turkel Y; Ekici A; Ekici M
    Respir Care; 2016 Aug; 61(8):1044-50. PubMed ID: 26932385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal analysis of functional disabilities, cognitive decline and risk of dementia in women with Parkinson's disease and detrusor overactivity.
    Campos-Sousa RN; Araújo de Sousa I; James Almeida K; Augusto Dias de Castro I; Cosme Soares de Oliveira-Filho M; M A B Quagliato E
    J Clin Neurosci; 2020 May; 75():85-88. PubMed ID: 32245601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulsion severity showed a good correlation with cognitive function in Parkinson's disease.
    Kurata T; Hatanaka N; Morimoto N; Deguchi S; Deguchi K; Ikeda Y; Abe K
    Neurol Res; 2014 Nov; 36(11):962-7. PubMed ID: 24836461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts.
    Liu G; Locascio JJ; Corvol JC; Boot B; Liao Z; Page K; Franco D; Burke K; Jansen IE; Trisini-Lipsanopoulos A; Winder-Rhodes S; Tanner CM; Lang AE; Eberly S; Elbaz A; Brice A; Mangone G; Ravina B; Shoulson I; Cormier-Dequaire F; Heutink P; van Hilten JJ; Barker RA; Williams-Gray CH; Marinus J; Scherzer CR; ; ; ; ; ; ;
    Lancet Neurol; 2017 Aug; 16(8):620-629. PubMed ID: 28629879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive profile of Parkinson's disease patients: a comparative study between early-onset and late-onset Parkinson's disease.
    Tang H; Huang J; Nie K; Gan R; Wang L; Zhao J; Huang Z; Zhang Y; Wang L
    Int J Neurosci; 2016; 126(3):227-34. PubMed ID: 26001202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profiles of cognitive subtest impairment in the Montreal Cognitive Assessment (MoCA) in a research cohort with normal Mini-Mental State Examination (MMSE) scores.
    Markwick A; Zamboni G; de Jager CA
    J Clin Exp Neuropsychol; 2012; 34(7):750-7. PubMed ID: 22468719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired Pain Processing Correlates with Cognitive Impairment in Parkinson's Disease.
    Okada A; Nakamura T; Suzuki J; Suzuki M; Hirayama M; Katsuno M; Sobue G
    Intern Med; 2016; 55(21):3113-3118. PubMed ID: 27803403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
    Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
    Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distal motor deficit contributions to postural instability and gait disorder in Parkinson's disease.
    Vervoort G; Bengevoord A; Nackaerts E; Heremans E; Vandenberghe W; Nieuwboer A
    Behav Brain Res; 2015; 287():1-7. PubMed ID: 25804361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of--or as well as--the MMSE?
    Larner AJ
    Int Psychogeriatr; 2012 Mar; 24(3):391-6. PubMed ID: 22014176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive performance in asymptomatic patients with advanced carotid disease.
    Popovic IM; Lovrencic-Huzjan A; Simundic AM; Popovic A; Seric V; Demarin V
    Cogn Behav Neurol; 2011 Sep; 24(3):145-51. PubMed ID: 21945986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement in Language Function Correlates with Gait Improvement in Drug-naïve Parkinson's Disease Patients Taking Dopaminergic Medication.
    Murakami H; Momma Y; Nohara T; Mori Y; Futamura A; Sugita T; Ishigaki S; Katoh H; Kezuka M; Ono K; Miller MW; Kawamura M
    J Parkinsons Dis; 2016; 6(1):209-17. PubMed ID: 26889633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.